Terms: = Lung cancer AND PTEN, MMAC1, 5728, MGC11227, PTEN1, MHAM, P60484, BZS, ENSG00000171862 AND Treatment
365 results:
1. Hibiscus manihot L. flower extract induces anticancer activity through modulation of apoptosis and autophagy in A549 cells.
Xu M; Zhao M; Zhu M; Yuan H; Li Z; Yan P; Ma C; Zhao H; Wang S; Wan R; Wang L; Yu G
Sci Rep; 2024 Apr; 14(1):8102. PubMed ID: 38582921
[TBL] [Abstract] [Full Text] [Related]
2. NDRG2 acts as a negative regulator of the progression of small-cell lung cancer through the modulation of the pten-AKT-mTOR signalling cascade.
Ma Z; Ma Y; Feng J; Xu Z; Cheng C; Qin J; Li S; Jiang J; Kong R
Toxicol Appl Pharmacol; 2024 Apr; 485():116915. PubMed ID: 38537875
[TBL] [Abstract] [Full Text] [Related]
3. Scutellarin, a flavonoid compound from Scutellaria barbata, suppresses growth of breast cancer stem cells in vitro and in tumor-bearing mice.
Ma H; Yue GG; Lee JK; Gao S; Yuen KK; Cheng W; Li X; Lau CB
Phytomedicine; 2024 Jun; 128():155418. PubMed ID: 38518647
[TBL] [Abstract] [Full Text] [Related]
4. Molecular mechanisms underlying the regulation of tumour suppressor genes in lung cancer.
Lee JY; Bhandare RR; Boddu SHS; Shaik AB; Saktivel LP; Gupta G; Negi P; Barakat M; Singh SK; Dua K; Chellappan DK
Biomed Pharmacother; 2024 Apr; 173():116275. PubMed ID: 38394846
[TBL] [Abstract] [Full Text] [Related]
5. Phase I Study of mTORC1/2 Inhibitor Sapanisertib (CB-228/TAK-228) in Combination with Metformin in Patients with mTOR/AKT/PI3K Pathway Alterations and Advanced Solid Malignancies.
Subbiah V; Coleman N; Piha-Paul SA; Tsimberidou AM; Janku F; Rodon J; Pant S; Dumbrava EEI; Fu S; Hong DS; Zhang S; Sun M; Jiang Y; Roszik J; Song J; Yuan Y; Meric-Bernstam F; Naing A
Cancer Res Commun; 2024 Feb; 4(2):378-387. PubMed ID: 38126764
[TBL] [Abstract] [Full Text] [Related]
6. Diagnostic Utility of Next-Generation Sequencing in Circulating Free DNA and a Comparison With Matched Tissue in Gallbladder Carcinoma.
Mishra S; Srivastava P; Pandey A; Shukla S; Agarwal A; Husain N
Lab Invest; 2024 Feb; 104(2):100301. PubMed ID: 38092180
[TBL] [Abstract] [Full Text] [Related]
7. Cisplatin-activated ERβ/DCAF8 positive feedback loop induces chemoresistance in non-small cell lung cancer via pten/Akt axis.
Hu Y; Xu Y; Zhang T; Han Q; Li L; Liu M; Li N; Shao G
Drug Resist Updat; 2023 Nov; 71():101014. PubMed ID: 37913652
[TBL] [Abstract] [Full Text] [Related]
8. The Role of microRNAs in Regulating cancer Cell Response to Oxaliplatin-Containing Regimens.
Tavakoli Pirzaman A; Ebrahimzadeh Pirshahid M; Babajani B; Rahmati A; Niknezhad S; Hosseinzadeh R; Taheri M; Ebrahimi-Zadeh F; Doostmohamadian S; Kazemi S
Technol Cancer Res Treat; 2023; 22():15330338231206003. PubMed ID: 37849311
[TBL] [Abstract] [Full Text] [Related]
9. Co-Occurring Alterations in Multiple Tumor Suppressor Genes Are Associated With Worse Outcomes in Patients With EGFR-Mutant lung cancer.
Stockhammer P; Grant M; Wurtz A; Foggetti G; Expósito F; Gu J; Zhao H; Choi J; Chung S; Li F; Walther Z; Dietz J; Duffield E; Gettinger S; Politi K; Goldberg SB
J Thorac Oncol; 2024 Feb; 19(2):240-251. PubMed ID: 37806385
[TBL] [Abstract] [Full Text] [Related]
10. Mechanism of Sophorae Flavescentis Radix (Kushen) in treating NSCLC: Insights from miRNA-mRNA network analysis.
Li J; Huang Y; Xu J; Zuo H; Tang Y; Huang HY; Chen J; Lin YC; Huang HD
J Ethnopharmacol; 2024 Jan; 319(Pt 3):117232. PubMed ID: 37757992
[TBL] [Abstract] [Full Text] [Related]
11. Potential of miR-181a-5p and miR-630 as clinical biomarkers in NSCLC.
Simiene J; Dabkeviciene D; Stanciute D; Prokarenkaite R; Jablonskiene V; Askinis R; Normantaite K; Cicenas S; Suziedelis K
BMC Cancer; 2023 Sep; 23(1):857. PubMed ID: 37697308
[TBL] [Abstract] [Full Text] [Related]
12. Circadian gene ARNTL initiates circGUCY1A2 transcription to suppress non-small cell lung cancer progression via miR-200c-3p/pten signaling.
Zhao D; Dong Y; Duan M; He D; Xie Q; Peng W; Cui W; Jiang J; Cheng Y; Zhang H; Tang F; Zhang C; Gao Y; Duan C
J Exp Clin Cancer Res; 2023 Sep; 42(1):229. PubMed ID: 37667322
[TBL] [Abstract] [Full Text] [Related]
13. Zerumbone-incorporated liquid crystalline nanoparticles inhibit proliferation and migration of non-small-cell lung cancer in vitro.
Manandhar B; Paudel KR; Clarence DD; De Rubis G; Madheswaran T; Panneerselvam J; Zacconi FC; Williams KA; Pont LG; Warkiani ME; MacLoughlin R; Oliver BG; Gupta G; Singh SK; Chellappan DK; Hansbro PM; Dua K
Naunyn Schmiedebergs Arch Pharmacol; 2024 Jan; 397(1):343-356. PubMed ID: 37439806
[TBL] [Abstract] [Full Text] [Related]
14. Detecting undetectable - epidemiology, etiology, and diagnosis of carcinoma of unknown primary - systematic review.
Ostojewska J; Wieczorek I; Pachciński O; Zdziennicki W; Burdan F
Folia Med Cracov; 2023 Apr; 63(1):19-37. PubMed ID: 37406274
[TBL] [Abstract] [Full Text] [Related]
15. Resistance to KRAS G12C Inhibition in Non-small Cell lung cancer.
Di Federico A; Ricciotti I; Favorito V; Michelina SV; Scaparone P; Metro G; De Giglio A; Pecci F; Lamberti G; Ambrogio C; Ricciuti B
Curr Oncol Rep; 2023 Sep; 25(9):1017-1029. PubMed ID: 37378881
[TBL] [Abstract] [Full Text] [Related]
16. The mechanism investigation of mutation genes in liver and lung metastasis of colorectal cancer by using NGS technique.
Liu K; Cui Y; Li H; Mi J; Wang H; Zhuang Y; Tang L; Liu J; Tian C; Zhang Z; Zhou J; Shi H; Tian X; Liu P
Crit Rev Oncol Hematol; 2023 Aug; 188():104057. PubMed ID: 37328085
[TBL] [Abstract] [Full Text] [Related]
17. pten Loss Confers Resistance to Anti-PD-1 Therapy in Non-Small Cell lung cancer by Increasing Tumor Infiltration of Regulatory T Cells.
Exposito F; Redrado M; Houry M; Hastings K; Molero-Abraham M; Lozano T; Solorzano JL; Sanz-Ortega J; Adradas V; Amat R; Redin E; Leon S; Legarra N; Garcia J; Serrano D; Valencia K; Robles-Oteiza C; Foggetti G; Otegui N; Felip E; Lasarte JJ; Paz-Ares L; Zugazagoitia J; Politi K; Montuenga L; Calvo A
Cancer Res; 2023 Aug; 83(15):2513-2526. PubMed ID: 37311042
[TBL] [Abstract] [Full Text] [Related]
18. Whole-exome and targeted gene sequencing of large-cell lung carcinoma reveals recurrent mutations in the PI3K pathway.
Guo JH; Ma YS; Lin JW; Jiang GX; He J; Lu HM; Wu W; Diao X; Fan QY; Wu CY; Liu JB; Fu D; Hou LK
Br J Cancer; 2023 Aug; 129(2):366-373. PubMed ID: 37179440
[TBL] [Abstract] [Full Text] [Related]
19. Molecular profiling and target actionability for precision medicine in neuroendocrine neoplasms: real-world data.
Boilève A; Faron M; Fodil-Cherif S; Bayle A; Lamartina L; Planchard D; Tselikas L; Kanaan C; Scoazec JY; Ducreux M; Italiano A; Baudin E; Hadoux J
Eur J Cancer; 2023 Jun; 186():122-132. PubMed ID: 37062210
[TBL] [Abstract] [Full Text] [Related]
20. Integrative Analysis of a Large Real-World Cohort of Small Cell lung cancer Identifies Distinct Genetic Subtypes and Insights into Histologic Transformation.
Sivakumar S; Moore JA; Montesion M; Sharaf R; Lin DI; Colón CI; Fleishmann Z; Ebot EM; Newberg JY; Mills JM; Hegde PS; Pan Q; Dowlati A; Frampton GM; Sage J; Lovly CM
Cancer Discov; 2023 Jul; 13(7):1572-1591. PubMed ID: 37062002
[TBL] [Abstract] [Full Text] [Related]
[Next]
